Ann: Medibio announces board changes and cost reduction plans, page-5

Great news and what I see as some very decisive positive action taken by our new CEO in less than one month that he has been in what is a very hot and uncomfortable seat I am sure.

Announcing 510k submissions to FDA as a short term measure until the FDA approval comes through, working on addressing the issues FDA has brought up, the resignation of the chairman which has been a long and contentious issue, the capital raising which was no surprise and the only way to keep us afloat and buy time, bringing on a major shareholder as a non executive director (yesss!!!) , trimming the staff in U.S / maximising current resources and the non executive directors not getting cash payment for services and instead a deal incentive still to come.

And finally, informing us that non executive aussie directors intend to put their hands in their pockets in the capital raising.

After so much waste of the last year, finally someone who seems to have his finger on the pulse. Keep up the great work!